Ray Dalio
CNK icon

Ray Dalio’s Cinemark Holdings CNK Stock Holding History

Ray Dalio’s Portfolio CNK Stock Details CNK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-43,276
Closed -$1.34M – 700
2024
Q4 		$1.34M Buy
+43,276
New +$1.34M 0.01% 478

Other funds holding CNK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Candlestick Capital Management Greenwich, Connecticut $4.12B AUM 50.27% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
SCM
Steadfast Capital Management New York $2.92B AUM 26.34% 1-Year Est. Return

Ray Dalio's CNK Position: Q1 2025 in Review

Ray Dalio sold out of Cinemark Holdings (CNK) in Q1 2025, closing a stake of 43,276 shares — an estimated $1.34M sold.

Ray Dalio first reported a position in CNK in Q4 2024 and held it in 1 quarter. The position peaked at $1.34M in Q4 2024. 273 funds tracked by Wall St. Rank hold CNK as of Q1 2025.

  • Ray Dalio reported no remaining Cinemark Holdings position as of Q1 2025 after selling out during the quarter.
  • Ray Dalio sold 43,276 Cinemark Holdings shares in Q1 2025, an estimated $1.34M.
  • Ray Dalio first reported a position in Cinemark Holdings in Q4 2024 and held it in 1 quarter.
  • Ray Dalio's Cinemark Holdings position peaked at $1.34M in Q4 2024.
  • 273 funds tracked by Wall St. Rank held Cinemark Holdings as of Q1 2025.

Based on Bridgewater Associates's 13F filing for Q1 2025, filed 14 May 2025.